Plasma natriuretic peptide levels increase with symptoms and severity of mitral regurgitation
Authors:
- Ralph A.H StewartRSRalph A.H Stewart
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Rapid Measurement of B-Type Natriuretic Peptide in the Emergency Diagnosis of Heart FailureNew England Journal of Medicine, 2002
- Evaluation and Management of Chronic Mitral RegurgitationNew England Journal of Medicine, 2001
- Plasma A- and B-type natriuretic peptides: physiology, methodology and clinical useCardiovascular Research, 2001
- ACC/AHA guidelines for the management of patients with valvular heart diseaseJACC, 1998
- Natriuretic PeptidesNew England Journal of Medicine, 1998
- Immunoreactive amino‐terminal pro‐brain natriuretic peptide (NT‐PROBNP): a new marker of cardiac impairmentClinical Endocrinology, 1997
- The Timing of Surgery for Severe Mitral RegurgitationNew England Journal of Medicine, 1996
- Left ventricular function after valve repair for chronic mitral regurgitation: Predictive value of preoperative assessment of contractile reserve by exercise echocardiographyJACC, 1996
- Effective mitral regurgitant orifice area: Clinical use and pitfalls of the proximal isovelocity surface area methodJACC, 1995
- Plasma brain natriuretic peptide in assessment of acute dyspnoeaThe Lancet, 1994